Nrc Health (NRC) Cash from Financing Activities (2010 - 2026)

Nrc Health has reported Cash from Financing Activities for 17 years, with the latest figure at -$6.9 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 28.7% year-over-year to -$6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.4 million (down 86.92% YoY) and the FY2025 annual result came in at -$15.8 million, up 5.52% from the prior year.
• Cash from Financing Activities slipped to -$6.9 million in Q1 2026 per NRC's latest filing, from -$4.1 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $6.9 million in Q2 2025 and troughed at -$24.0 million in Q3 2023.
• A 5-year average of -$8.0 million and a median of -$5.9 million in 2023 frame the typical range for Cash from Financing Activities.
• The widest YoY moves for Cash from Financing Activities: up 353.52% in 2025, down 77723.53% in 2025.
• Over 5 years, Cash from Financing Activities stood at -$9.5 million in 2022, then surged by 46.45% to -$5.1 million in 2023, then jumped by 77.25% to -$1.2 million in 2024, then slumped by 255.8% to -$4.1 million in 2025, then slumped by 67.67% to -$6.9 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$6.9 million, -$4.1 million, and -$13.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.